课题基金 / 基金详情

Analysis of telomerase activity and telomere length in various liver diseases

Analysis of telomerase activity and telomere length in various liver diseases
各种肝脏疾病的端粒酶活性及端粒长度分析
批准号:
08670557
负责人:
IMAZEKI Fumio
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

IMAZEKI Fumio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Telomere, a repititive sequence which resides in the end of chromosomes, shortens during cell division and telomerase activity, which can restore the length of telomere array and immortalize the cell, has been frequently detectable in various malignant tumors. We examined the telomerase activity in 26 hepatocellular carcinomas together with corresponding nontumorous tissues and 20 chronic hepatitis tissues without tumors by TRAP assay. Telomerase activity was found in 22 (85%) of 26 tumor tissues, in 3 (12%) of 26 corresponding nontumorous tissues and in one (5%) of 20 chronic hepatitis tissues. Telomerase activity was detected in tumorous tissues irrespective of the tumor size or the degree of tumor differentiation and we further analyzed quantitatively the telomerase activity in 28 small hepatocellular carcinomas obtained by ultrasonography guided liver biopsy. The mean telomerase activity in 25 tumors, in 3 borderline lesions and in 28 corresponding nontumorous tissues was 133.7(]SY.+-。[)197.3 arbitrary units (AU) , 11.7(]SY.+-。[)11.3 AU and 4.5(]SY.+-。[)7.5 AU,respectively. Nineteen (76%) of 25 tumorous tissues and one (33%) of 3 borderline lesions showed the telomerase activity over 19.5 AU,the mean value plus twice the standard deviation of the activity in nontumorous tissues, in contrast only one (4%) of 28 nontumorous tissues. The telomerase activity was strongly detected in a majority of small hepatocellular carcinoma, while almost no or faint activity was detectable in a majority of nontumorous specimens. The quantitative assay of telomerase activity was considered to be useful in the diagnosis of small hepatocellular carcinoma.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Hiroshige Kojima et al: "Telomerase activity and telomere length in hepatocellulan carcinoma and chronic liver disease" Gastroenterology. 112. 493-500 (1997)
Hiroshige Kojima 等人:“肝细胞癌和慢性肝病中的端粒酶活性和端粒长度”胃肠病学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Analysis of nonalcoholic fatty liver using androgen receptor transgenic mouse
  • 批准号:
    21590828
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2009
  • 负责人:
    IMAZEKI Fumio
  • 依托单位:
Genome-wide screen for hepermethylated genes in hepatocellular carcinoma
  • 批准号:
    13670490
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.18万
  • 财政年份:
    2001
  • 负责人:
    IMAZEKI Fumio
  • 依托单位:
Functional analysis of HCV core protein using HCV core transgenic mouse
  • 批准号:
    11670476
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.3万
  • 财政年份:
    1999
  • 负责人:
    IMAZEKI Fumio
  • 依托单位:
Analysis of clonality in hepatocellular carcinoma
  • 批准号:
    05670448
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.41万
  • 财政年份:
    1993
  • 负责人:
    IMAZEKI Fumio
  • 依托单位:
国内基金
海外基金
SAGE1通过调控TERT转录促进肿瘤细胞增殖的机制研究
  • 批准号:
    32100582
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    葛云辉
  • 依托单位:
HnRNP F/H在调控端粒酶活性、组装和转运中的作用和机制研究
  • 批准号:
    32070733
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    陈军
  • 依托单位:
CST蛋白复合体在端粒复制中对端粒酶移除与C链填补调控的分子机制研究
  • 批准号:
    31900521
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2019
  • 负责人:
    冯旭阳
  • 依托单位:
核仁蛋白TCOF1影响端粒复制的分子机制研究
  • 批准号:
    31970683
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    刘海英
  • 依托单位: